{
    "2021-05-03": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie's Humira Still Number 1 in Drug Sales",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "Drug Sales"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "3 High-Yield Stocks for Dividend Investors",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Stocks",
                        "Dividend"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "This Is Why Humira Isn't AbbVie's Biggest Problem Right Now",
                "features": {
                    "keywords": [
                        "Humira",
                        "AbbVie",
                        "Problem"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-18",
                "original_text": "Is It Time To Buy AbbVie Stock As It Barrels Toward A New Buy Point?",
                "features": {
                    "keywords": [
                        "Buy",
                        "AbbVie",
                        "Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}